Reported Earlier, Healthcare-Focused SPAC JATT III Acquisition Corp Prices $60M Initial Public Offering Of 6M Ordinary Shares At $10.00 Per Share

8-K filing — JATT II Acquisition Corp. (JATT)

Filed: 2026-06-29 AccNo: 0001193125-26-286926 Size: 11 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

JATT II Acquisition To Merge With Talawar Therapeutics; Combined Company Expects To Receive $285M In PIPE Financing Upon Closing